|
|||||
|
|
Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON-HF trial |
|
| Authors: | Safia Chatur Brian L. Claggett Orly Vardeny Karola Jering Akshay S. Desai Marc A. Pfeffer Martin Lefkowitz John J.V. McMurray Scott D. Solomon Muthiah Vaduganathan |
| Affiliation: | 1. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA;2. Minneapolis VA Center for Care Delivery and Outcomes Research, University of Minnesota, Minneapolis, MN, USA;3. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA;4. BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK |
| Abstract: | |
| Keywords: | Heart failure with preserved ejection fraction Sacubitril/valsartan Diuretics |